ERBB2 and breast carcinoma: In luminal B breast cancer, membrane receptors such as HER2, HER3, and EGFR (HER1) can reside and interact within cholesterol enriched domains, thus creating activated receptor platforms that support rapid signaling (Gueguinou et al., 2015; Marquez & Pietras, 2001).